title: Attacking breast cancer at the preinvasion stage by targeting autophagy.
abstract: Preinvasive breast carcinoma cells that proliferate and accumulate within the nonvascular, closed intraductal niche are under severe hypoxic and metabolic stress. Understanding the survival mechanisms used by these cells has revealed therapeutic strategies for killing preinvasive neoplasms. We have found that autophagy ('self-eating') is a major survival strategy used by preinvasive carcinoma and breast cancer stem-like cells. Based on this finding, we have opened a clinical trial that is exploring neoadjuvant oral chloroquine antiautophagy therapy for ductal carcinoma in situ. We envision that antiautophagy therapy can be administered in combination with other treatments such as those that elevate intracellular calcium, to create a state of intolerable stress for preinvasive neoplastic cells, and thereby stop breast cancer before it starts.
authors.affiliation: George Mason University, Center for Applied Proteomics & Molecular Medicine, Manassas, VA 20110, USA.
authors.forename: Virginia
authors.initials: V
authors.lastname: Espina
authors.forename: John
authors.initials: J
authors.lastname: Wysolmerski
authors.forename: Kirsten
authors.initials: K
authors.lastname: Edmiston
authors.forename: Lance A
authors.initials: LA
authors.lastname: Liotta
mesh_terms: D001343:Autophagy; D001943:Breast Neoplasms / Q000503:physiopathology*; D002278:Carcinoma in Situ; D045744:Cell Line, Tumor; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D014411:Neoplastic Stem Cells / Q000473:pathology*; D055153:Stem Cell Niche